WO2002102235A2 - Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer - Google Patents

Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer Download PDF

Info

Publication number
WO2002102235A2
WO2002102235A2 PCT/US2002/019297 US0219297W WO02102235A2 WO 2002102235 A2 WO2002102235 A2 WO 2002102235A2 US 0219297 W US0219297 W US 0219297W WO 02102235 A2 WO02102235 A2 WO 02102235A2
Authority
WO
WIPO (PCT)
Prior art keywords
hs
ests
protein
ss
tm
Prior art date
Application number
PCT/US2002/019297
Other languages
French (fr)
Other versions
WO2002102235A3 (en
Inventor
David H. Mack
Kurt C. Gish
Original Assignee
Eos Biotechnology Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US29923401P priority Critical
Priority to US60/299,234 priority
Priority to US31528701P priority
Priority to US60/315,287 priority
Priority to US60/317,544 priority
Priority to US31754401P priority
Priority to US35066601P priority
Priority to US60/350,666 priority
Priority to US60/372,246 priority
Priority to US37224602P priority
Application filed by Eos Biotechnology Inc. filed Critical Eos Biotechnology Inc.
Publication of WO2002102235A2 publication Critical patent/WO2002102235A2/en
Publication of WO2002102235A3 publication Critical patent/WO2002102235A3/en

Links